CAS NO: | 1275595-86-2 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | Selatinib is a reversible and orally active dualEGFRandErbB2inhibitor withIC50s of 13 nM and 22.5 nM, respectively. Selatinib has anticancer effects[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 565.06 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C29H26ClFN4O3S | ||||||||||||||||
CAS 号 | 1275595-86-2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(176.97 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |